We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$20.6M
Cap. Flow %
-7.77%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.51M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.08M
3
GLHAW
Glass Houses Acquisition Corp. Warrant
GLHAW
+$2.88M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.74M
5
PFE icon
Pfizer
PFE
+$2.35M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Consumer Staples 6.03%
5 Real Estate 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEM icon
176
Newmont
NEM
$98.5B
– –
-2,000
Closed -$84K
NWBI icon
177
Northwest Bancshares
NWBI
$2.25B
– –
-10,000
Closed -$135K
PCYO icon
178
Pure Cycle
PCYO
$260M
– –
-80,000
Closed -$668K
RMR icon
179
The RMR Group
RMR
$348M
$0 ﹤0.01%
16
-398
-96% -$10.8K
RY icon
180
Royal Bank of Canada
RY
$291B
– –
-2,500
Closed -$225K
TECK icon
181
Teck Resources
TECK
$29.3B
– –
-50,000
Closed -$1.52M
TGNA
182
DELISTED
TEGNA Inc
TGNA
– –
-3,000
Closed -$62K
EIGR
183
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-13,643
Closed -$3.08M
SPPI
184
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-36,900
Closed -$16K
HVBC
185
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
– –
-25,000
Closed -$519K
FSTX
186
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-235,945
Closed -$1.21M
CNCE
187
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-50,000
Closed -$335K
MSAC
188
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
– –
-200,000
Closed -$1.98M
GLHAW
189
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
– –
-250,000
Closed -$2.88M
LGV
190
DELISTED
Longview Acquisition Corp. II
LGV
– –
-63,900
Closed -$627K
LGV.WS
191
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
– –
-12,780
Closed -$147K
QTNT
192
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-40,837
Closed -$245K
4 5 6 7
8

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $20.6M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.